Brief: Lee's Pharmaceutical Says Stock Exchange Has Granted Approval For Listing Of Zhaoke Ophthalmology Shares
29/04/2021 09:51
April 29 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* STOCK EXCHANGE HAS GRANTED APPROVAL FOR LISTING OF ZHAOKE
OPHTHALMOLOGY SHARES
* LISTING OF ZHAOKE OPHTHALMOLOGY ON MAIN BOARD OF STOCK
EXCHANGE
TOOK PLACE ON 29 APRIL
* RECORDED A GAIN OF ABOUT HK$2.32 BILLION ON DERECOGNITION
OF
INVESTMENT IN ZHAOKE OPHTHALMOLOGY
Source text for Eikon: ID:nHKSLcTpx
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals